Strong environment X genotype interactions determine the fitness costs of antibiotic resistance in vitro and in an insect model of infection (article) by Manktelow, CJ et al.
 1 
Strong environment X genotype interactions determine the fitness costs of antibiotic 1 
resistance in vitro and in an insect model of infection 2 
 3 
C. James Manktelow1,2, Elitsa Penkova2, Lucy Scott2, Andrew Matthews2, Ben 4 
Raymond*1,2. 5 
 6 
1 Silwood Park campus, Imperial College, Ascot, SL5 7PY, UK.  2 Centre for Ecology 7 
and Conservation, University of Exeter, Penryn campus, Penryn, TR10 9FE, UK. 8 
*Corresponding author 9 
Running head: 10 
In vivo and in vitro resistance costs uncorrelated 11 
 12 
  13 
 2 
Abstract 14 
The acquisition of antibiotic resistance commonly imposes fitness costs, a reduction in the 15 
fitness of bacteria in the absence of drugs. These costs have been primarily quantified using 16 
in vitro experiments and a small number of in vivo studies in mice, and it is commonly 17 
assumed that these diverse methods are consistent. Here, we used an insect model of 18 
infection to compare the fitness costs of antibiotic resistance in vivo relative to in vitro 19 
conditions.   Experiments explored diverse mechanisms of resistance in a Gram-positive 20 
pathogen, Bacillus thuringiensis, and a Gram-negative intestinal symbiont, Enterobacter 21 
cloacae.  Rifampicin resistance in B. thuringiensis showed fitness costs that were typically 22 
elevated in vivo, although these were modulated by genotype-environment interactions. In 23 
contrast, resistance to cefotaxime via de-repression of AmpC β-lactamase in E. cloacae 24 
resulted in undetectable costs in vivo or in vitro, while spontaneous resistance to nalidixic 25 
acid, and carriage of the IncP plasmid RP4, imposed costs that increased in vivo. Overall, 26 
fitness costs in vitro were a poor predictor of fitness costs in vivo because of strong genotype 27 
environment interactions throughout this study. Insect infections provide a cheap and 28 
accessible means of assessing fitness consequences of resistance mutations, data that is 29 
important to understand the evolution and spread of resistance.  This study emphasizes that 30 
the fitness costs imposed by particular mutations or different modes of resistance are 31 
extremely variable, and that only a subset of these mutations are likely to be prevalent 32 
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Antibiotics target enzymes with essential cell functions, such as RNA polymerase, DNA 41 
gyrase and the 30S or 50S subunits of the ribosome, while resistance mutations in binding 42 
sites can impair essential biochemical functions such as transcription (1, 2). Though 43 
mutations in drug targets confer a fitness advantage in the presence of antibiotic over some 44 
range of doses, they also typically reduce fitness in the absence of antibiotics (3-5). This 45 
detrimental consequence of resistance is commonly described as a fitness cost (3-5). While 46 
target site mutations are obvious candidates for imposing high fitness costs, the acquisition 47 
of plasmids bearing antibiotic resistance genes can also reduce fitness (6-8). Moreover, 48 
while the individual cost of each additional gene encoding for resistance can be small (4, 9, 49 
10), the cumulative effect of increasing numbers of resistance genes is associated with 50 
impaired growth (11). 51 
A greater understanding of the evolutionary biology of resistance, including fitness costs, can 52 
inform efforts to control the spread of resistance (3, 12-14).  A range of approaches to 53 
antimicrobial stewardship increase the heterogeneity of selection pressure by prescribing 54 
different drugs to different parts of the population (‘mixing’), or by using preferred drugs for 55 
short periods of time (‘cycling’).  Under cycling strategies in particular, the fitness costs of 56 
resistance (12, 15) and patient turnover (16) are expected to be the main factors driving 57 
down the frequency of resistance when drugs are withdrawn. Modelling studies have argued 58 
that there are insufficient data to estimate some of these key parameters (16, 17) or to 59 
predict which antibiotic stewardship interventions would be most effective (18). 60 
Importantly, antibiotic resistance mechanisms are diverse and not all will necessarily impose 61 
a cost: there will be a distribution of fitness effects (5). Most commonly, fitness costs are 62 
assessed in vitro and results are extrapolated to costs in vivo (4). While some have argued 63 
that fitness costs are broadly similar in vitro and in vivo (10), this is not universally accepted 64 
(4). Some resistance mutations in a range of microbes show enhanced or altered costs in 65 
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vivo (4, 19-21).  In addition, resistance mutations seen in clinical contexts often represent a 66 
low-cost subset of those detectable in vitro (20, 22, 23), the implication being that selection 67 
based on fitness costs might be particularly efficient in vivo. Arguably, in vivo conditions are 68 
likely to be harsher than in vitro and environmental stress can increase fitness costs in a 69 
wide range of organisms (24-26). Although this pattern is by no means universal (1),   70 
environmental conditions could substantially affect antibiotic resistance fitness costs (1, 4, 71 
25) and there are still limited comparative data on costs in vivo and in vitro (10). 72 
Previous experimental studies of in vivo costs are almost entirely restricted to mouse models 73 
(10). In this study, we wanted to explore the practicality of a cheaper, higher-throughput 74 
insect model. Secondly, previous in vivo studies have focused on spontaneous target site 75 
modifications in housekeeping genes, where pleiotropic fitness costs are likely to be high (4, 76 
10). Here, we compare spontaneous target site resistance with metabolic resistance based 77 
on constitutive up-regulation of β-lactamases.  Finally, we incorporated a measure of the cost 78 
of carriage of a typical antibiotic resistance plasmid because there are limited data on the 79 
costs of plasmid carriage in vivo (10),  80 
To examine the difference in antibiotic resistance fitness costs in vitro and in vivo, this study 81 
used an insect model of infection and two different microbes, a Gram-positive pathogen 82 
Bacillus thuringiensis, and a Gram-negative intestinal symbiont, Enterobacter cloacae.  Wax 83 
moth, Galleria melonella, are a commonly used insect model for bacterial infections partly 84 
because they can be reared at 37°C (27).  Insects also have a well-developed innate 85 
immune system that shares several features with vertebrates (27, 28).    However, wax moth 86 
larvae have weak immunity relative to many insects, with reduced expression of antimicrobial 87 
peptides (29) and weak cellular based immunity to macro-parasites such as nematodes (30, 88 
31).  Their status as permissive hosts for infection generally means that they are widely used 89 
as traps for the isolation of new insect parasites (32, 33).     90 
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Weak immunity may make wax moth a questionable host for assessing in vitro fitness costs 91 
of antibiotics and studying antibiotic resistance.   There is abundant circumstantial evidence 92 
suggesting immunity is important for the fitness of resistant microbes.  For instance, 93 
repressed immunity may facilitate the persistence of high cost resistance mechanisms (34, 94 
35) and active immunity is thought to be important for shaping the fitness of drug resistance 95 
mutation in HIV(36).   Since interactions with the immune system may be an important factor 96 
for fitness costs this study used larvae (caterpillars) of an alternative host, diamondback 97 
moth, Plutella xylostella, which is a well-established infection model for both B. thuringiensis 98 
and E. cloacae (37-40).  While this insect cannot be reared at 37°C, it has high fecundity and 99 
a short generation time (ca. 14 days at 25°C) can be reared gnotobiotically on artificial diet in 100 
Petri dishes (41), making it a valuable alternative model host. 101 
 102 
Results  103 
Characterization of mutants 104 
Sequencing of the rifampicin-binding pocket of rpoB in the B. thruringiensis mutants gave 37 105 
sequences that could be aligned with the wild type template. This region is 216 base pairs 106 
long, starting at base 1,054 in the template rpoB gene. All the mutants contained one of five 107 
SNPs, each a single base pair substitution that resulted in a single amino acid change (Table 108 
1).  Amino acid alignments for these mutants are presented in supplementary figure S1. The 109 
Ser-Tyr mutants (9a) could not be reliably cultured and these were excluded from fitness 110 
experiments; one mutant from each of the remaining genotypes was used in subsequent 111 
experiments. All mutants had minimal inhibitory concentrations (MICs) at least 100x greater 112 
than that of the wild type (Table 1). 113 
After 48h of incubation on cefotaxime-supplemented agar (4 µg/ml), two distinct phenotypes 114 
of resistant E. cloacae mutants were observed: satellite colony-forming and non-satellite 115 
colony forming mutants (see Supplementary Fig. S2). Satellite colonies were susceptible 116 
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cells, which were able to grow on agar plates containing 4µg/ml cefotaxime in the zone 117 
around a resistant mutant colony. Satellite colonies were phenotypically susceptible and not 118 
able to grow on cefotaxime in the absence of a mutant colony. Satellite colonies are 119 
produced when -lactamases detoxify solid media and facilitate the growth of susceptible 120 
cells coming out of persister states (6).  121 
Eight mutants of each resistant phenotype were sequenced at two potential target genes: 122 
ampD and ampR. Sequences were assembled and analyzed using a wild type positive 123 
control and the annotated reference genome of E. cloacae KU6334, Sequence ID: 124 
AY789446 (42) and wild type ancestor of experimental strains E. cloacae jjbc. No genetic 125 
changes were observed in sequences of the ampD gene. In contrast, sequence variation 126 
was found in the ampC transcriptional activator gene ampR, resulting a range of genetic 127 
variants, three of which were used in experiments (see Table 2). Two genotypes produced 128 
satellite colonies (cef D-A and cef D-Y); the third (cef ins) did not. Genotypes cef D-A and cef 129 
D-Y had non-synonymous single base pair mutations on the same codon, at positions 410 130 
and 409, respectively. Fitness experiments were conducted with one mutant for each of 131 
these genotypes.   Two additional mutants with substitutions affecting the same residue, 132 
resulting in a change to Glycine or Valine, were isolated but not used further. All three 133 
experimental genotypes had MICs at least 100-fold greater than the wild type, although the 134 
cef-ins genotype, which did not produce satellite colonies, had the lowest MIC of all strains 135 
used (Table 2). 136 
Nalidixic acid resistant mutants of E. cloacae, capable of growth at 30ug/ml could be readily 137 
produced. However, all characterized clones had wild type sequences in both gyrA and parC. 138 
MIC values (<0.1mg/ml) were modest compared to those of clinical fluoroquinolone-resistant 139 
isolates of E. cloacae, which are commonly >100mg/ml nalidixic acid (43, 44). We selected a 140 
single mutant (11.1B) for fitness experiments to act as a comparison for the cefotaxime 141 
resistant mutants; this genotype was also the host for the RP4 transconjugants. 142 
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Relative fitness 143 
For the rifampicin resistant mutants of B. thuringiensis we observed strong 144 
environment*genotype interaction effects on competitive fitness in the absence of antibiotics 145 
(F3,206 = 26.0, P < 0.0001; Fig 1); and strong differences between genotypes (F3,201 = 59.6, P 146 
< 0.0001). As hypothesized we saw lower mutant fitness overall in larvae, and therefore 147 
enhanced fitness costs for the in vivo infections (F1,209 = 25.9, P < 0.0001; Fig 1).  In broth B. 148 
thuringiensis typically underwent 11.9 doublings (se 0.35), and our estimate of the typical 149 
number generations in vivo was 13.0 (se 0.08), although this assumes an initial infection 150 
bottleneck of 50 cells. 151 
In E. cloacae, the fitness cost imposed by resistance depended on the particular resistance 152 
mechanism (F4,139 = 72.4, P < 0.0001, Fig 2A). As hypothesized, the fitness costs of 153 
resistance could be enhanced in vivo, but this was only true for nalidixic acid resistance and 154 
carriage of RP4 plasmid (genotype*treatment interaction F4,135 = 41.1, P < 0.0001, Fig 2A).  155 
Carriage of RP4 was the only resistance trait that imposed a detectable cost in vitro (Fig 2A). 156 
The enhanced fitness cost of RP4 in vivo was not as clear in our supplementary analysis on 157 
the estimates of Malthusian parameters (Fig S3). Note that both these analyses excludes 9 158 
replicates in which relative fitness could not be calculated because plasmid carrying cells 159 
could not be detected in live hosts but which support a picture of poor fitness in that 160 
environment.  In the E. cloacae experiments there was greater disparity in the number of 161 
generations in different environments- with 11.1 generations in broth (se 0.05) and 162 
approximately 17.5 generations in larvae (se 0.17). 163 
The three cefotaxime resistant genotypes of E. cloacae behaved similarly and for these three 164 
genotypes there no was no evidence that environment affected fitness (treatment*genotype 165 
interaction F1,93 = 1.21, P = 0.3, Fig 2A) nor was there a significant impact of genotype (F1,95 166 
= 1.17, P = 0.31). There was some evidence that the competitive fitness of resistant mutants 167 
in larvae was actually slighter greater than the wild type (test for fitness > 0, mean 0.186, SE 168 
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0.08, t = 2.306, P = 0.0232); for the cef D-Y mutant in particular the mean fitness had 169 
confidence intervals (0.55,0.15) that did not overlap with zero, indicating a fitness benefit for 170 
this mutation. 171 
Using data from both E. cloacae and B. thuringiensis we also assessed whether fitness costs 172 
in broth culture were correlated with costs in vivo, as investigated previously (10).  We found 173 
that fitness costs in vitro were a poor predictor of costs in vivo, based on a simple linear 174 
model of mean log-transformed fitness values (Rsq = 0.035, F1,7 = 0.25, P = 0.63; Figure 3). 175 
While growth rates or relative fitness in direct competition are the most commonly reported 176 
measures of fitness, there are other fitness components that likely impact on pathogen 177 
transmission, such as the total population size of infectious propagules within a host, 178 
sometimes termed yield (4).  For the three cefotaxime resistant mutants we had sufficient 179 
data to conduct a yield analysis. An important biological factor for naturalistic in vivo infection 180 
is the existence of a considerable bottleneck during establishment (45). The infection 181 
bottleneck in E. cloacae meant that 50 larvae carried infections consisting of single 182 
genotypes (either the wild type or resistant mutant).  With these infections competitive fitness 183 
cannot be calculated and yield offers an important complementary fitness parameter. The 184 
high number of zero yield counts for one partner or another (Fig 2B) meant that data were 185 
not normally distributed. However, a non-parametric analysis indicated that resistant mutants 186 
reached higher population size than wild type bacteria within larvae (paired Wilcoxon rank 187 
test of yield, V = 1783, P < 0.0001, Fig 2B). The slight excess of infections in which the wild 188 
type strain failed to establish (37 wild type out of the 50 single genotype infections) 189 
contributed to this pattern (Fig 2B). Again, there was no good evidence for differences in 190 
yield in infections between the three cefotaxime resistant mutants (Kruskal one way ANOVA 191 
 = 3.2, df = 2, P = 0.2).  192 
Discussion 193 
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The fitness costs of antibiotic resistance are well established. However, the literature directly 194 
comparing such costs in vitro and in vivo is very limited (10), potentially because conducting 195 
in vivo studies in mice is both costly and laborious. As a result, tractable model systems 196 
present a valuable opportunity to close this knowledge gap and potentially inform antibiotic 197 
stewardship.  We investigated genotype-environment interactions on the fitness costs of 198 
rifampicin resistance in B. thuringiensis because of the clinical importance of rifampicin 199 
resistance in other Gram-positive organisms (23) but also because rifampicin has been used 200 
to develop a well-established model of the genetics of resistance (1, 4, 5, 46, 47).  201 
Comparisons of data from the insect model to prior studies can give us some idea of the 202 
value of this system.  Encouragingly, we found that distinct mutations in the rifampicin 203 
binding pocket produced a distribution of fitness costs, as in prior studies, although the range 204 
of mutations isolated is reduced relative to those seen in Pseudomonas aeruginosa or UV-205 
irradiated Bacillus anthracis (5, 48). Here, we were also able to demonstrate that fitness 206 
costs were consistently higher in vivo, although this effect varied with genotype. This result is 207 
also consistent with the apparent efficiency of selection on limiting the diversity of mutations 208 
seen in clinical studies (23).  209 
Intestinal infection of E. cloacae in moth larvae also constituted an experimentally tractable 210 
model for the spontaneous evolution of resistance to third generation cephalosporins. For 211 
instance, it was possible to readily isolate a number of independent mutations that are 212 
consistent with the constitutive up-regulation of AmpC -lactamases, as seen in clinical 213 
Enterobacteriaceae (42, 49, 50). In contrast to all other resistance mechanisms in this study, 214 
AmpC up-regulation imposed undetectable fitness costs in media. This result is consistent 215 
with previous in vitro work on the low costs of plasmid-encoded extended spectrum -216 
lactamases (9) and AmpC -lactamases (51). Comparative studies suggest that some 217 
classes of -lactamase impose costs, but the dominant mechanisms found in the clinic 218 
appear to be the classes that impose the lowest fitness costs (52, 53).  219 
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In this study, we found some evidence that AmpC up-regulation conferred a slight fitness 220 
benefit in vivo, both in terms of competitive fitness and population size. This is difficult to 221 
explain and should be treated with caution, although a range of resistance mutations can 222 
provide context dependent fitness benefits (54). Methods of calculating relative fitness here 223 
are not without bias or limitations, particularly since wild type susceptible bacteria lack 224 
independent markers. Nevertheless, similar biases should pertain to in vivo and in vitro 225 
treatments and both treatments used identical methods for scoring genotypes and common 226 
inoculation methods.  The production of -lactams by resident microbes is possible, but 227 
unlikely, given than insects are reared in near aseptic conditions (41).  Finally, -lactam 228 
production by arthropods has been described but this is thought to be extremely rare and 229 
must be considered a very remote possibility (55). Of speculative interest is the fact that the 230 
insect pathogen B. thuringiensis carries multiple -lactamase genes (56) while its close 231 
relative, B. anthracis, is typically -lactam sensitive and is a mammalian pathogen (57), 232 
suggesting that -lactamases may have some fitness benefits in insect infections.  233 
The insect infection model yielded valuable fitness cost data for both Gram-negative and 234 
Gram-positive bacteria. Not all drug classes or resistance modes were equally amenable to 235 
study. We believed it would be easy to isolate fluoroquinolone resistance conferring 236 
mutations in gyrA and parC, but these proved elusive and may be much rarer than we 237 
anticipated, or not easily recoverable in this genetic background. Alternative sites for 238 
fluoroquinolone resistance are efflux pumps or MarR, which are known to be an important 239 
source of mutations in other Enterobactericeae (58, 59), and these could account for the 240 
resistance phenotypes here. In addition, our isolate of insect-associated E. cloacae appears 241 
to be poorly adapted for the carriage of a classic IncP plasmid: the plasmid appears to be 242 
non-conjugative when in this background (60) and this study shows that it imposes high 243 
fitness costs. IncP plasmids can conjugate into a broad range of bacteria (61). Nevertheless, 244 
this does not mean these plasmids are able to persist and be transmitted in all recipient 245 
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genetic backgrounds (62), a fact which can explain the restricted distribution of plasmids in 246 
the field (63).  247 
Overall, there are several possible mechanisms that could account for elevated fitness costs 248 
in vivo.  Since growth in host requires expression of a range of virulence factors not required 249 
in media, one hypothesis is that resistance mechanisms affecting gene expression impose 250 
greater costs in vivo (19). Since the costs of plasmid carriage commonly manifest through 251 
disrupted gene expression (64, 65), this is one possible explanation for elevated costs of 252 
plasmid carriage in vivo that merits further study. In addition to the fundamental differences in 253 
nutrient supply between in vitro and in vivo conditions that can alter fitness costs (54) host 254 
immunity may have an important role in altering or increasing fitness costs.  For instance, 255 
interactions with macrophages can shape environment dependent fitness costs of rifampicin 256 
resistance (66) while all growth rate based fitness costs could confer increased susceptibility 257 
to immune cells. Moreover, a range of spontaneous resistance mutations can confer 258 
increased sensitivity to antimicrobial peptides, especially for mutations that affect the make-259 
up of the cell wall (67, 68). One possibility that is unlikely to be important here is the 260 
presence of competing microbial species, since experiments used gnotobiotic insects; other 261 
studies have shown that a community context can be important for shaping the evolution of 262 
resistance (69). 263 
One consequence of the experimental techniques used here is that naturalistic oral infections 264 
lead to strong infection bottlenecks, which will increase the variation in measures of 265 
competitive fitness and produce a proportion of single genotype or clonal infections (45). This 266 
can be thought of as methodological benefit, or a drawback.  Bottlenecks are commonly 267 
produced during the process of infection, and so hosts are frequently colonized by single 268 
genotypes (70-72). With a single genotype per host, selection on competitive fitness will be 269 
weak as within-host competition occurs infrequently, so parameter estimates of competitive 270 
fitness may not reflect the transmission potential of resistant mutants. Instead, competition 271 
between hosts and selection on traits such as population size and efficiency of transmission 272 
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will be more critical (73).  In this case, experiments that incorporate establishment of infection 273 
and can measure population size are valuable. If, on the other hand, it is important to 274 
measure competitive fitness precisely, experiments with insects can use injection rather than 275 
oral feeding to overcome bottlenecks (38), or can simply increase sample sizes to cope with 276 
noise (74). 277 
We have previously argued that fitness costs of resistance are not necessarily a reliable 278 
basis for antimicrobial stewardship (13). This is partly because compensatory mutations that 279 
reduce fitness can occur quickly and readily (64, 65). This study emphasizes that the fitness 280 
burden of different mechanisms or mutations may be magnified in vivo but also that fitness 281 
costs vary considerably with genotype. This does not necessarily improve our prospects for 282 
exploiting fitness costs. Instead, one consequence is that elevated costs in vivo shape 283 
mutation supply, by determining which mutations or resistance mechanisms are able to 284 
persist effectively and establish in clinical contexts (14, 21, 23, 52).  Similarly, while the 285 
horizontal mobility of resistance plasmids is often emphasized, clinically resistant microbes 286 
are often dominated by the clonal expansion of successful lineages with effective 287 
compensation in place.  The success of the Escherichia coli lineage ST131, an unholy 288 
alliance of plasmid-borne -lactamases, chromosomal fluoroquinolone resistance and 289 
plasmid compensation, is a well-known example (75). If high cost resistance is transient or 290 
exceptional (14) then it will be a poor basis for antibiotic resistance management. Antibiotic 291 
stewardship efforts may be better served by studying in detail the fitness of resistance 292 
lineages that are the targets of antibiotic stewardship (12), rather than on a general 293 
assumption of high fitness cost. 294 
 295 
Materials and Methods 296 
Bacterial isolates 297 
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Bacillus thuringiensis kurstaki 7.1.o is a recently isolated wild type strain (Bt WT) which is 298 
highly pathogenic to many Lepidoptera (41). This isolate has sequence type 8, placing it 299 
within an abundant and successful clonal expansion in this species (76). Enterobacter 300 
cloacae jjbc was recently isolated from the midgut of diamondback moth Plutella xylostella 301 
larvae and forms a persistent symbiotic association with this host (38). 302 
Independent resistant mutants were produced via a modified fluctuation test based on (5). In 303 
brief, overnight cultures were diluted into LB in 24 well plates such that each well contained 304 
1ml of broth inoculated with approximately 102 cells. Plates were cultured overnight at 30°C 305 
and the resulting cultures centrifuged (5000g, 8mins) and re-suspended in 200µl of saline 306 
(0.85% NaCl).  Re-suspended cells were spread over LB agar plates containing either 307 
10µg/ml rifampicin (B. thuringiensis only), 4µg/ml cefotaxime or 30µg/ml nalidixic acid. 308 
Colonies with strong growth were re-streaked at least twice on media containing antibiotics 309 
before sequencing and storage of glycerol stocks. RP4 transconjugants of E. cloacae were 310 
produced by co-streaking Escherichia coli MG1655 carrying the Inc P plasmid RP4 (provided 311 
by Tatiana Dimitriu) with a nalidixic acid resistant mutant (11.1B NalR) of E. cloacae on agar 312 
plates. Transconjugants were identified by re-plating cells on nalidixic acid and tetracyline. 313 
The RP4 plasmid is essentially non-conjugative in this system (60).  For experiments 314 
antibiotic resistant mutants were cultivated by streaking wildtype ancestors from glycerol 315 
stock onto selective antibiotic plates followed by growth overnight in Lysogeny Broth (LB) at 316 
30°C. 317 
Characterization of antibiotic resistant mutants 318 
 MICs of wild type and resistant colonies were determined by broth dilution methods in 319 
microtiter plates using a two-fold dilution series of antibacterial agents, as per EUCAST 320 
recommendations (77).  MICs were defined as the lowest concentrations of drug that 321 
completely inhibited visible growth of the inoculum after incubation for 18h at 30°C.  322 
PCR and sequencing 323 
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B. thuringiensis clones were then sequenced to identify mutations in rpoB. The primers used 324 
to amplify the rpoB gene in B. thuringiensis were RIF-F1 (5’ CGTGAGAGAATGTCGATCC) 325 
and RIF-R1 (5’ CGCGAACGAAGATAATGA) for the cluster I region β-subunit in RNA 326 
polymerase (48). The ampD and ampR genes of cefotaxime resistant E. cloacae clones were 327 
targeted for PCR using primers from M. Hilty et al. (78) or designed in house: ampR 328 
EcAmpR_74F (5’-TGTGCCTGACAAACGGTTAA-3’) and EcAmpR_1112R (5’-329 
AGCGGTAAAGGGGTCTTCTA-3’); ampD_F (5’-TATTAATACGTTCCAGAAGC-3’); and 330 
ampD_R (5’-CATGGTAAACAACGTCATGT-3’).   331 
For the nalidixic acid resistant mutants of E. cloacae, we amplified gene fragments at two loci 332 
typically associated with fluouroquinolone resistance in Enterobacteriaceae: gyrase A and 333 
the ParC subunit of topoisomerase IV (parC) (43, 44). PCRs used the following primers: 334 
EcGyrA_1734F (5’- CGCATACCGTCTTTGTCAGA 3’); EcGryA_2672 (5’-335 
TGCGAGAGAAATTACACCGG-3’); ParC_970F (5’-CAGAATCGCCTGAAGCTGAT-3’), 336 
ParC_2088R (5’- GCCAAGTTCAAGAAATCCG-3’). 337 
 338 
All PCR reactions used 25µl volume reactions with 0.4μl 0.2mM dNTPs, 0.4μl of each primer 339 
required at 25nM, 0.1μl 0.05U AmpliTaq DNA polymerase, and 1.5μl of the template DNA 340 
(overnight culture mixed with equal volumes of Tris-HCl ph8.0, boiled for 10mins). PCR 341 
conditions for rpoB amplification used: initial denaturation at 95°C for 5mins, thereafter 35 342 
cycles of denaturation at 95°C for 30s, annealing at 52°C for 30s, extension at 72°C for 30s, 343 
and final extension at 72°C for 7mins.  Amplification of ampR used similar conditions, but 344 
with an annealing temperature of 54°C, while all other PCRs (ampD, gyrA,parC) used an 345 
annealing temperature of 56°C. PCR reactions were subject to ExoSAP cleanups using 0.2μl 346 
Exonuclease I (NEB, 20,000 U/ml) 0.1μl Antarctic phosphatase (NEB) and 1.5μl ExoI buffer 347 
per 10μl of PCR product. Products were incubated in a thermocycler for 30mins at 37°C and 348 




Competition experiments 352 
All mutants were competed against the wild type ancestor in vitro and in vivo, with the 353 
exception of the RP4 transconjugant, which was competed against the relevant plasmid null 354 
strain, the nalidixic acid resistant E. cloacae mutant 11.1B.  All comparisons of fitness in vitro 355 
and in vivo were assessed using a common inoculum master mix of wild type and resistant 356 
bacteria.  B. thuringiensis inocula used spores, while the E. cloacae experiment used 357 
stationary phase cells. Each inoculum was plated on selective LB agar containing antibiotics 358 
and on antibiotic-free LB agar and incubated overnight at 30°C to establish initial and final 359 
ratios of resistant bacteria. Spores of B. thuringiensis were produced, pasteurized and 360 
enumerated via colony forming counts as described previously (39), stocks of spores for 361 
each genotype were prepared at 500cfu/µl. Inoculants for in vitro treatments were prepared 362 
by mixing stocks in 1:1 ratio with the wild type ancestors, and 10µl of each inoculant was 363 
added to 1ml LB in 24 well plates. Mixtures of wild type and resistant E. cloacae mutants 364 
were prepared from overnight cultures in LB (30°C, shaking at 180rpm). Cultures were 365 
diluted ten-fold in sterile saline (0.85% NaCl) and, after adjusting for differences in optical 366 
density at 600nm, were mixed with their ancestors in 1:1 ratio. E. cloacae cultures were also 367 
inoculated with 10µl of each mixture, the final dilutions being equivalent to a 1,000x dilution 368 
of overnight cultures. All experiments used a minimum of six replicates, each culture plate 369 
used six wells with uninoculated broth as checks for contamination, and in vitro competitions 370 
were run for 18h at 30°C and repeated twice.  371 
For in vivo competition treatments P. xylostella larvae, from the population VLSS, were 372 
raised in gnotobiotic conditions on sterile diet as described previously (79). Ten third instar 373 
larvae were inoculated in 50mm Petri dishes using 100µl of each inoculant; all inoculation 374 
took place at 25°C. Inocula were added to the surface of a quarter of sterile caterpillar diet 375 
and allowed to dry in a class 2 safety cabinet. B. thuringiensis stocks were used at the total 376 
dose of 1000cfu/ µl, as above; this dose confers approximately 100% mortality with this 377 
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pathogen (39). E. cloacae mixtures were diluted a further 100-fold to give a final inoculum 378 
concentration equivalent to 1000x dilution of overnight cultures.  Previous work has shown 379 
that this dose of E. cloacae ensures effective colonization of midgut but minimizes 380 
pathogenic effects (38).   381 
Cadavers killed by B. thuringiensis were recovered after three to four days and final ratios of 382 
resistant and wild type spores assessed in homogenized cadavers as described previously 383 
(74). In brief, cadavers were incubated at 30°C for five days to ensure complete sporulation 384 
before being pasteurized, homogenized in a bead-beater (Qiagen Tissue Lyzer II) and 385 
dilution plated. Inoculation methods were adjusted for the gut symbiont E. cloacae. 386 
Approximately 50 eggs (just prior to hatching) were placed in Petri dishes containing 387 
inoculated diet, emergent larvae were allowed to feed for 48h before being transferred to 388 
fresh uninoculated diet for another 48-72h and then homogenized for bacterial enumeration. 389 
This ensures that experimental larvae are carrying persistent gut infections, not simply the 390 
initial inocula, and are approximately the same size as B. thuringiensis-killed insects (early 391 
third instars). Each master mix was inoculated into at least 32 larvae, although not all insects 392 
yielded data suitable for analysis of competitive fitness. 393 
In vitro & in vivo fitness 394 
The proportions of each strain and the ancestral competitor were calculated using total 395 
colonies on LB agar and the resistant colonies on selective agar plates. If the number of 396 
colonies on antibiotic plates was equal to, or exceeded, the LB agar counts, the proportion of 397 
wild type bacteria was inferred to be zero. Initial and final proportions on both LB and 398 
antibiotic-supplemented LB plates were used to calculate relative fitness V, where V = x2(1 - 399 
x1)/x1(1 - x2), x1 being the initial proportion of resistant mutants in inoculum and x2 their final 400 
proportion (80). Fitness analyses were also conducted using the ratio of the Malthusian 401 
parameters, W. This method, however, relies on indirect estimation of the initial infection 402 
bottleneck in insects, while in vitro initial densities are calculated directly. We preferred to use 403 
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a parameter that was less subject to this potential bias, although analyses using W produced 404 
qualitatively similar results (Supplementary Fig S3). 405 
Data availability. 406 
The Genbank accession for the genome of the wild type B. thuringiensis 7.1.o is 407 
PRJNA395643 (76).  A draft genome of E. cloaceae jjbc is available through the JGI 408 
Genome Portal, with the reference tag  Anc C2.  Raw experimental data for this project are 409 
publicly available from the University of Exeter institutional repository (unique doi to be 410 
allocated following acceptance). 411 
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 621 
Table 1. Characterization of spontaneous rifampicin resistant colonies of B. thuringiensis 622 
with mutations in rpoB. All genotypes bar 9a were used in competition experiments. The MIC 623 
for the B. thuringiensis wild type was 0.2 g / ml. 624 
 625 
Mutant ID MIC  g / 
ml 




Number of mutants 
isolated 
11c 100 18 Glu  Lys 1 
4b 200 18 Glu  Arg 5 
2d 100 31 His  Asp 10 
10a 100 36 Ser  Phe 17 
9a 100 36 Ser  Tyr 4 
 626 
 627 
Table 2.  Characterization of spontaneous cefotaxime resistant colonies of E. cloacae with 628 
mutations in the transcriptional regulator gene ampR.  *These mutants produced satellite 629 
colonies on LB agar plates containing 4 µg/ml cefotaxime.  The MIC for the wild type E. 630 
cloacae was 0.25 µg/ml.   631 
Mutant 
ID 
MIC  µg / 
ml 
Mutation Position of 
mutation (bp) 
Amino Acid Change Number of 
mutants isolated 
cef D-A* 256 A to C 410 Asp  Ala 2 
cef D-Y* 256 G to T 409 Asp Tyr 2 
cef ins 64 25 bp insertion Starts at 370 + Asp, Leu, Gln, Leu, 
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Figure 1. The relative fitness of four rifampicin resistant mutants of B. thuringiensis in pairwise 635 
competition assays against the WT ancestor in vitro (LB) and in oral in vivo infections in larvae of 636 
diamondback moth, P. xylostella.  Boxplots shows medians and interquartile distances, data points are 637 
independent infections of insects or replicated broth culture.  Fitness was calculated according to the 638 
change in proportion of resistant and wild type genotypes from initial inoculum to end of 639 
culture/infection. 640 
Figure 2. A. The relative fitness of diverse antibiotic resistant mutants of E. cloacae in pairwise 641 
competition assays against the WT ancestor in vitro (LB) and in oral in vivo infections in larvae of 642 
diamondback moth, P. xylostella. Fitness was calculated according to the change in proportion of 643 
resistant and wild type genotypes from initial inoculum to end of culture/infection. B.  The total 644 
population size of cefotaxime resistant mutants and wild type E. cloacae in live intestinal larval 645 
infections.   Zero counts reflect infections in which single genotypes were recovered from larvae.  646 
Boxplots shows medians and interquartile distances; data points are independent infections of insects 647 
or replicated broth culture.  On the x- axis cefotaxime resistant genotypes (with the prefix cef) are 648 
listed in Table 2, nal and RP4 refer to a spontaneous nalidixic acid resistant mutant and a carrier of 649 
the IncP plasmid RP4, respectively. 650 
Figure 3.  Competitive fitness in vitro was a poor predictor of the fitness costs of resistance in vivo 651 
during live larval infections. Data are mean log10 transformed fitness values for the different resistance 652 
genotypes of both E. cloacae and B. thuringiensis in this study; the line represents the fitted linear 653 
model with a 95% confidence interval.  654 
 655 
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